| 9B, Hemophilia Specialty Pharmacy Program |
| 9C |
| 9D |
| 9D, Off Label Antipsychotic Safety Monitoring in Beneficiaries Through Age 17 |
| 9E |
| 9E, Off Label Antipsychotic Safety Monitoring in Beneficiaries 18 and Older |
| Acceptable Use Policy (AUP) |
| Aduhelm Injection |
| Agents Duchenne Muscular Dystrophy |
| Agents for Duchenne Muscular Dystrophy |
| Ambulance Clinical Coverage Policies |
| Antifungal Agents - Vusion |
| Antifungal Agents Vusion |
| Antinarcolepsy Antihyperkinesis Agents |
| Antinarcolepsy/Antihyperkinesis Agents |
| Antiparkinsons Agents |
| Behavioral Health Clinical Edits Criteria - Adults |
| Behavioral Health Clinical Edits Criteria - Pediatrics |
| Chiropractic Services Clinical Coverage Policies |
| Cialis |
